Prevalence of rheumatic manifestations and antineutrophil cytoplasmic antibodies in haematological malignancies. A prospective study

Rheumatology

Volumn 39, Issue 4, 2000, Pages 417-420

  Hamidou, M A ^a   Derenne, S ^a   Audrain, M A P ^a   Berthelot, J M ^a   Boumalassa, A ^a   Grolleau, J Y ^a  

^a HÔTEL DIEU   (France)

Author keywords

Antineutrophil cytoplasmic antibodies; Lymphoma; Myelodysplasia; Polymyalgia rheumatica; Rheumatic manifestations; Vasculitis

Indexed keywords

MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ARTICLE; BLOOD DISEASE; CANCER; FASCIITIS; FEMALE; GIANT CELL ARTERITIS; HUMAN; LEUKOCYTOCLASTIC VASCULITIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; MYELOMONOCYTIC LEUKEMIA; POLYARTERITIS NODOSA; POLYARTHRITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELAPSING POLYCHONDRITIS; RHEUMATIC DISEASE; RHEUMATIC POLYMYALGIA; SYSTEMIC VASCULITIS; TUBERCULOSIS; VASCULITIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; POLYMYALGIA RHEUMATICA; PREVALENCE; PROSPECTIVE STUDIES; RHEUMATIC DISEASES; VASCULITIS;

EID: 0034122835     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Naschitz JE, Rosner I, Rozenbaum M, Elias N, Yeshurun D. Cancer-associated rheumatic disorders. Semin Arthritis Rheum 1995;24:231 41.
2. Kurzrock R, Cohen PR. Mucocutaneous paraneoplastic manifestations of hematologic malignancies. Am J Med 1995;99:207-16.
3. Mufti GJ, Figes A, Hamblin TJ, Oscier DJ, Copplestone JA. Immunological abnormalities in myelodysplastic syndromes. Br J Haematol 1986;63:143-7.
4. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Gatlin DAG, Granlick HR. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51: 189-99.
5. Audrain MAP, Baranger TAR, Moguilevski N et al. Antinative and recombinant myeloperoxidase monoclonals and human autoantibodies. Clin Exp Immunol 1997; 107:127 34.
6. Castro M, Conn DL, Su DWP, Carton JP. Rheumatic manifestations in myelodysplastic syndromes. J Rheumatol 1991;18:721-7.
7. Enright H, Miller W. Autoimmune phenomena in patients with myelodysplastic syndromes. Leuk Lymphoma 1997;24:483-9.
8. Sanchez-Guerrero J, Gutierrez-Urena S, Vidaller A, Reyes E, Iglesias A, Alarcon-Segovia D. Vasculitis as a paraneoplastic syndrome. Report of 11 cases and review of the literature. J Rheumatol 1990;17:1458-62.
9. Kuzmich PV, Ecker GA, Karch J. Rheumatic manifestations in patients with myelodysplastic and myeloproliferative syndromes. J Rheumatol 1994;21:1649-54.
10. Mertz LE, Conn DL. Vasculitis associated with malignancy. Curr Opin Rheumatol 1992;4:39-46.
11. Fain O, Guillevin L, Kaplan G et al. Vascularites et néoplasies. Quatorze observations. Ann Med Interne 1991;142:486 504.
12. Philippe B, Couderc L-J, Droz D et al. Systemic vasculitis and myelodysplastic syndromes. A report of two cases. Arthritis Rheum 1997;40:179-82.
13. Warren AJ, Hegde UM, Nathwani A, Reilly IA. Systemic vasculitis and myelodysplasia. Br J Haematol 1990;75: 627-9.
14. Pirayesh A, Verbunt RJAM, Kluin PHM, Meinders AE, De Meijer PHEM. Myelodysplastic syndrome with vasculitis manifestations. J Intern Med 1997;242:425-31.
15. Kohli M, Bennett RM. An association of polymyalgia rheumatica with myelodysplastic syndromes. J Rheumatol 1994;21:1357-9.
16. Berthelot JM, Hamidou M, Dauty M, Rodet D, Maugars Y, Prost A. Joint manifestations in myelodysplastic syndromes. A report of three cases presenting as polymyalgia rheumatica. Rev Rheum 1997;64:95-100.
17. Diebold J, Rauh G, Jäger K, Löhrs U. Bone marrow pathology in relapsing polychondritis: high frequency of myelodysplastic syndromes. Br J Haematol 1995;89: 820-30.
18. Billström R, Johansson H, Johansson B, Mitelman F. Immune-mediated complications in patients with myelo-dysplastic syndromes - clinical and cytogenetic features. Eur J Haematol 1995;55:42-8.
19. Heaney ML, Golde DW. Myelodysplasia. N Engl J Med 1999;340:1649 60.
20. Gilligan HM, Bredy B, Brady HR et al. Antineutrophil cytoplasmic autoantibodies interact with primary granule constituents on the surface of apoptotic neutrophils in the absence of neutrophil priming. J Exp Med 1996;184: 2231-41.
21. Hoffman GS, Specks U. Antineutrophil cytoplasmic antibodies. Arthritis Rheum 1998;41:1521-37.
22. Youinou P, Mackenzie LE, Lamour A, Mageed RA, Lydyard PM. Human CD5-positive B cells in lymphoid malignancy and connective tissue diseases. Eur J Clin Invest 1993;23:139-50.
23. Billström R, Johansson B, Strömbeck B et al. Clonal CDS-positive B lymphocytes in myelodysplastic syndrome with systemic vasculitis and trisomy 8. Ann Hematol 1997;74:37-40.
24. Savige JA, Chang L, Smith CL, Duggan JC. Myelodysplasia, vasculitis and anti-neutrophil cytoplasm antibodies. Leuk Lymphoma 1993;9:49-54.
25. Savige JA, Chang L, Smith CL, Duggan JC. Antineutrophil cytoplasmic antibodies (ANCA) in myelodysplasia and other haematologic disorders. Aust NZ J Med 1994;24:282-7.
26. Komatsuda A, Miura I, Ohtani H et al. Crescentic glomerulonephritis accompanied by myeloperoxydase-antineutrophil cytoplasmic antibodies in a patient having myelodysplastic syndrome with trisomy 7. Am J Kidney Dis 1998;31:336-40.
27. Zuckerman KK, Leventhal L, Wynne C. Positive c-ANCA in a patient with lymphoma and without vasculitis. J Clin Rheumatol 1997;3:279-81.
28. Hull DR, McMillan SA, Rea IM, Boyd N, McMullin MF. Antineutrophil cytoplasmic antibodies in myelodysplasia. Ulster Med J 1996;65:55-7.
29. Maillefert JF, Pfitzenmeyer P, Thenet M et al. Prevalence of ANCA in a hospitalized elderly French population. Clin Exp Rheumatol 1997;15:603-7.
30. Esnault VLM, Jayne DRW, Keogan MT et al. Antineutrophil cytoplasmic antibodies in patients with monoclonal gammopathies. J Clin Lab Immunol 1990;32:153-9.